Olema Oncology, a California-based biopharma company focused on developing targeted therapies for women’s cancers, has raised $54 million in a Series B financing round, which was co-led by BVF Partners, Logos Capital, and Janus Henderson Investors. The US biopharma company will use the proceeds for advancing OP-1250, its lead drug candidate in breast cancer, into […]
July 23, 2020Read More
New Ibrance FDA approval : The US Food and Drug Administration (FDA) has extended the approval of Pfizer breast cancer drug Ibrance (palbociclib) to cover the treatment of hormone receptor positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer in male patients. Latest Ibrance FDA approval Under the new indication approved […]
Continue reading …
As per the latest research reports, it was found that cannabis oil compounds are capable of killing malignant cells of cancer. Cannabis is used as a food supplement in the Western countries and is sold legally. Cannabis oil for breast cancer treatment Cannabis oil was used by a 69 year old woman for the treatment […]
Continue reading …
Belgium-based The University of Antwerp is all set to conduct its first clinical trial to reduce the severity of the cognitive deficit associated with breast cancer treatment. For this, the University of Antwerp will be using a video game training and assessment, scientifically-designed by UK-based My Cognition which focuses on cognitive health. Breast Cancer Cognitive […]
Continue reading …